![]() |
| Source: rediff news |
"About 52,000 patients in India are on kidney dialysis. It’s only 4 percent to 33 percent of the cost in the U.S., but too rich for most Indians."
Georgi Abraham one of India's most respected and senior nephrologist talks about the situation: “There’s a huge demand for dialysis centers, but only those who can afford it get it” ....Often I find that patients just disappear. They get one or two sessions when they have some money and then stop. Within a week or two of stopping dialysis, they may just collapse and die.”
"More than 90 percent of the 230,000 people who develop chronic kidney failure each year in India die within months because of lack of treatment, according to a 2009 study by the All India Institute of Medical Sciences and the Health Ministry....[yet] the Indian market for kidney care may grow to $152 million next year from $97 million in 2007, forecasts researcher Global Markets Direct. "
Surprisingly, until now, there has been no attempt to develop minimum standards. Companies claim that they are the best with little to support the claim. Some sketchy operators dialyze without even any attempt at purifying the water. Mohan Rajapurkar a senior nephrologist and pioneer in dialysis at MPUH in Nadiad Gujurat has, along with other nephrologists and the endorsement of the Indian Society of Nephrology, developed some guidelines for dialysis facilities. These guidelines have been presented to the Indian Government and people are waiting to hear whether these guidelines will be adopted by the government.

The bottom-line is that while dialysis in India is a small sliver of the global dialysis market (see figure), it is growing rapidly. However, like many developing countries India needs to go on two tracks - on the one hand regulate facilities to ensure that minimum standards are met and second increase the availability and access to dialysis for everyone - especially the poor who currently die because they cannot afford treatment. Currently, it's doing neither very well.

Seeing these photos is definitely very touching. Sometimes its easy to forget how blessed we are in the United States that no one can be denied these life saving treatments.
ReplyDeleteThanks for such an insightful and informative blog! I enjoyed reading.
Yes I agree it's a very good insight into how India have cut the gap between people who have and do not have by distributing wealth. How can a rich guy live with poverty outside his door?
ReplyDeleteThis is an eye opening article. The numbers are staggering when you think about the disparity between how things are treated in the United States.
ReplyDeleteThank you for sharing.
A great post. The tragedy of dialysis in India healthcare is simply not a political a government priority. India deals badly not only with ESRD but also with communicable diseases which to a large extent are easy and cheap to eradicate.
ReplyDeleteWe also discussed this very issue here http://www.gkaonlineacademy.com/blog/4401-kidney-disease-how-do-we-improve-global-outcomes
This is magnificent information..... keep updating your blog. Thanks a lot for the share.... Thanks!
ReplyDeleteTaking anti-HIV drugs Atazanavir can lead to the risk of kidney stones
ReplyDeleteAccording to the latest research, taking - ritonavir-boosted atazanavir (ATV / r) of the patients developed more than 10 times higher than the chances of kidney stones than patients taking other protease inhibitors. Because if the patient continues taking ATV / r, kidney stones, easy to relapse, a Japanese researcher from the National Center for Global Health and Medicine and his team should stop the use of the drugs recommended for any patients with kidney stones. 52nd interdisciplinary meeting of anti-microbial agents and chemotherapy, Dr. Hamada reported this finding. "Ritonavir-boosted atazanavir kidney stone risk factors, this drug may cause kidney stones patients should be used with caution, it is recommended that most patients with existing kidney damage, avoid the use of the drug.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
EMD-1214063
MI-2
MLN 2480
Lorcaserin hydrochloride
Darunavir
Darunavir ethanolate
GPR120 modulator 1
JNJ-38877605
Tivantinib